XML 23 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Operating activities    
Net income $ 78,051 $ 69,973
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation 7,021 6,338
Amortization 696 622
Share-based compensation 4,657 4,111
Excess tax benefits from share-based compensation (3,920) (3,187)
Equity earnings in unconsolidated investments (133) (55)
Other (73) (1,633)
Changes in operating assets and liabilities, net of effects of acquisitions:    
Receivables (180,075) (165,713)
Product inventories (21,936) (24,134)
Prepaid expenses and other assets (1,350) 459
Accounts payable 18,065 39,458
Accrued expenses and other current liabilities 48,109 40,783
Net cash used in operating activities (50,888) (32,978)
Investing activities    
Acquisition of businesses, net of cash acquired (4,612) (1,188)
Purchase of property and equipment, net of sale proceeds (11,921) (10,500)
Other investments, net 96 29
Net cash used in investing activities (16,437) (11,659)
Financing activities    
Proceeds from revolving line of credit 457,218 399,472
Payments on revolving line of credit (380,665) (329,928)
Proceeds from asset-backed financing 121,600 0
Payments on asset-backed financing (13,600) 0
Payments on long-term debt and other long-term liabilities 0 (10)
Excess tax benefits from share-based compensation 3,920 3,187
Proceeds from stock issued under share-based compensation plans 6,335 13,489
Payments of cash dividends (18,410) (16,308)
Purchases of treasury stock (88,745) (10,437)
Net cash provided by financing activities 87,653 59,465
Effect of exchange rate changes on cash and cash equivalents (771) (355)
Change in cash and cash equivalents 19,557 14,473
Cash and cash equivalents at beginning of period 8,006 12,463
Cash and cash equivalents at end of period $ 27,563 $ 26,936